| scholarly article | Q13442814 |
| P50 | author | Kate McKeage | Q102146108 |
| Katherine A Lyseng-Williamson | Q47824623 | ||
| P2860 | cites work | Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials. | Q52562217 |
| Spleen tyrosine kinase inhibition: a new promising approach to chronic and refractory immune thrombocytopenia. | Q52764290 | ||
| Immune thrombocytopenia | Q26830918 | ||
| The ITP syndrome: pathogenic and clinical diversity | Q33384235 | ||
| The incidence of immune thrombocytopenic purpura in children and adults: A critical review of published reports | Q33388124 | ||
| Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP) | Q33439412 | ||
| R406, an orally available spleen tyrosine kinase inhibitor blocks fc receptor signaling and reduces immune complex-mediated inflammation | Q34562439 | ||
| Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies | Q36987997 | ||
| Pharmacokinetic Properties of Fostamatinib in Patients With Renal or Hepatic Impairment: Results From 2 Phase I Clinical Studies. | Q38401096 | ||
| The contribution of VEGF signalling to fostamatinib-induced blood pressure elevation | Q38925714 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P2507 | corrigendum / erratum | Correction to: Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA | Q59797979 |
| P433 | issue | 10 | |
| P921 | main subject | chronic immune thrombocytopenia | Q1088037 |
| P304 | page(s) | 451-456 | |
| P577 | publication date | 2018-08-29 | |
| P1433 | published in | Drugs and Therapy Perspectives | Q15760081 |
| P1476 | title | Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA | |
| P478 | volume | 34 |
| Q90291421 | Fungal Infections with Ibrutinib and Other Small-Molecule Kinase Inhibitors | cites work | P2860 |
Search more.